↓ Skip to main content

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
11 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd007649.pub3
Pubmed ID
Authors

Ruiz Garcia V, Jobanputra P, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Kynaston-Pearson FJ, Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort‐Marti, Francis JB Kynaston‐Pearson

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
South Africa 1 1%
Singapore 1 1%
Sri Lanka 1 1%
Spain 1 1%
Unknown 90 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 16%
Researcher 15 16%
Student > Ph. D. Student 14 15%
Student > Bachelor 13 14%
Student > Doctoral Student 8 8%
Other 20 21%
Unknown 10 11%
Readers by discipline Count As %
Medicine and Dentistry 47 49%
Psychology 6 6%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Social Sciences 5 5%
Other 9 9%
Unknown 17 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2018.
All research outputs
#1,850,847
of 13,406,897 outputs
Outputs from Cochrane database of systematic reviews
#4,482
of 10,585 outputs
Outputs of similar age
#30,033
of 207,643 outputs
Outputs of similar age from Cochrane database of systematic reviews
#104
of 218 outputs
Altmetric has tracked 13,406,897 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.9. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,643 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.